Effect of EGFR Mutations on Survival in Patients following Surgical Resection of Lung Adenocarcinoma

被引：0

作者：

Laidlaw, Grace ^{[1
]}

Gao, Rebecca ^{[1
]}

Ayers, Kelsey ^{[2
]}

Backhus, Leah ^{[2
]}

Berry, Mark ^{[2
]}

Shrager, Joseph ^{[2
]}

机构：

[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA

[2] Stanford Univ, Sch Med, Cardiothorac Surg, Stanford, CA 94305 USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期

关键词：

EGFR; lung adenocarcinoma; sublobar resection;

D O I：

10.1016/j.jtho.2016.11.1000

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.08-033

引用

页码：S751 / S751

页数：1

共 50 条

[41] Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma [J].

Marks, Jenifer L. ;

Broderick, Stephen ;

Zhou, Qin ;

Chitale, Dhananjay ;

Li, Allan R. ;

Zakowski, Maureen F. ;

Kris, Mark G. ;

Rusch, Valerie W. ;

Azzoli, Christopher G. ;

Seshan, Venkatraman E. ;

Ladanyi, Marc ;

Pao, William .

JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (02) :111-116

[42] Mutational Characteristics and Clinical Outcomes for Lung Adenocarcinoma With EGFR Germline Mutations [J].

Pan, Kelsey ;

Owens, Jennifer ;

Elamin, Yasir ;

Lu, Charles ;

Routbort, Mark ;

Zhang, Jianjun ;

Fossella, Frank ;

Negrao, Marcelo V. ;

Altan, Mehmet ;

Pozadzides, Jenny ;

Skoulidis, Ferdinandos ;

Tsao, Anne ;

Cascone, Tina ;

Heymach, John, V ;

Ostrin, Edwin ;

Le, Xiuning .

JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) :1438-1448

[43] Association between human papillomavirus and EGFR mutations in advanced lung adenocarcinoma [J].

Li, Ming ;

Deng, Fang ;

Qian, Li-Ting ;

Meng, Shui-Ping ;

Zhang, Yang ;

Shan, Wu-Lin ;

Zhang, Xiao-Lei ;

Wang, Bao-Long .

ONCOLOGY LETTERS, 2016, 12 (03) :1953-1958

[44] The Incidence of EGFR-Activating Mutations in Bone Metastases of Lung Adenocarcinoma [J].

Krawczyk, Pawel ;

Nicos, Marcin ;

Ramlau, Rodryg ;

Powrozek, Tomasz ;

Wojas-Krawczyk, Kamila ;

Sura, Sylwia ;

Jarosz, Bozena ;

Szumilo, Justyna ;

Warda, Edward ;

Mazurkiewicz, Tomasz ;

Sawicki, Marek ;

Milanowski, Janusz .

PATHOLOGY & ONCOLOGY RESEARCH, 2014, 20 (01) :107-112

[45] Clinical Impact of EGFR vs KRAS Mutations in Multifocal Lung Adenocarcinoma [J].

Jiang, J. ;

Berry, M. F. ;

Lui, N. S. ;

Liou, D. Z. ;

Trope, W. L. ;

Backhus, L. M. ;

Shrager, J. B. .

JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) :S484-S485

[46] The Impact of Acquired EGFR T790M Mutation and EGFR Circulating Cell-Free DNA on Survival in Patients with Lung Adenocarcinoma Following EGFR-TKI Therapy [J].

Cheng, Wen-Chien ;

Hsia, Te-Chun ;

Tu, Chih-Yen ;

Chen, Hung-Jen .

ONCOTARGETS AND THERAPY, 2020, 13 :13425-13435

[47] Terminal respiratory unit type lung adenocarcinoma is associated with distinctive EGFR immunoreactivity and EGFR mutations [J].

Peterson, Michael R. ;

Piao, Zhe ;

Bazhenova, Lyudmila A. ;

Weidner, Noel ;

Yi, Eunhee S. .

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2007, 15 (03) :242-247

[48] Detection of EGFR Mutations in Cerebrospinal Fluid of EGFR-Mutant Lung Adenocarcinoma With Brain Metastases [J].

Shi, Liang ;

Tang, Junfang ;

Tao, Hong ;

Guo, Lili ;

Wu, Weihua ;

Wu, Hongbo ;

Liu, Zichen ;

Tong, Li ;

Wu, Wei ;

Li, Hongxia ;

Meng, Qiyi ;

Xu, Liyan ;

Che, Nanying ;

Liu, Zhe .

FRONTIERS IN ONCOLOGY, 2021, 11

[49] Survival prediction for patients with lung adenocarcinoma: A prognostic risk model based on gene mutations [J].

Geng, Hua ;

Li, Shixiong ;

Guo, Yixian ;

Yan, Fang ;

Han, Yuebin ;

Xu, Meilin ;

Cui, Yanzhi .

CANCER BIOMARKERS, 2020, 27 (04) :525-532

[50] Monitoring of cyclooxygenase-2 levels can predict EGFR mutations and the efficacy of EGFR-TKI in patients with lung adenocarcinoma [J].

Li, Huanhuan ;

Wang, Yuli ;

Su, Fan ;

Li, Jing ;

Gong, Ping .

INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (05) :5577-5583

← 1 2 3 4 5 →